Results 101 to 110 of about 102,354 (220)

A systematic review of stereotactic radiosurgery for pituitary metastases. [PDF]

J Neurooncol
Kite T, Harikumar N, Jaffee S, Knox H, Herbst J, Karlovits S, Yu A, Leonardo J, Wegner RE, Shepard MJ.   +9 more
europepmc   +1 more source

Stereotactic radiosurgery for pilocytic astrocytoma: A single center retrospective study. [PDF]

Neurosurg Rev
Senyurek S, Kayir I, Yildirim DC, Duzkalir AH, Askeroglu MO, Peker S.   +5 more
europepmc   +1 more source

Management of intracranial melanoma metastasis with radiosurgery: a case report and literature review

Revista Médica del Hospital General de México
Malignant melanoma is a devastating disease with a 5-year survival rate of approximately 20%. At the time of diagnosis, approximately 4% of patients had metastatic disease and between 5% and 20% had brain metastases.
Diana P. Duarte-Mora, Manuela Rondón-López, Luis O. Rojas-Romero   +2 more
doaj  

Loss of pituitary hormone function after stereotactic radiosurgery for pituitary adenomas: mechanisms and management. [PDF]

J Neurooncol
Faraj CA, McCutcheon IE.
europepmc   +1 more source

Stereotactic Radiosurgery [PDF]

Neurosurgical Focus, 2007
Lawrence S. Chin, N. Scott Litofsky
openaire   +1 more source

Safety and effectiveness of stereotactic radiosurgery for larger hemangioblastomas (>2cc): A multi-center retrospective study. [PDF]

PLoS One
Pichardo-Rojas PS, Tos SM, Mantziaris G, Shaaban A, Nabeel AM, Reda WA, Tawadros SR, AbdelKarim K, El-Shehaby AMN, Emad RM, Wei Z, McKendrick LM, Niranjan A, Lunsford LD, Peker S, Samanci Y, Liscak R, May J, Mathieu D, Lee CC, Yang HC, Dono A, Blanco AI, Esquenazi Y, Moreno NM, Álvarez RM, Picozzi P, Franzini A, Tripathi M, Sumi T, Uzuka T, Kano H, Bailey D, Zacharia BE, Cifarelli CP, Cifarelli DT, Hack JD, Speckter H, Lazo E, Warnick RE, Schoenhals JE, Palmer JD, Xu Z, Sheehan JP.   +43 more
europepmc   +1 more source

Salvage microsurgery for vestibular schwannoma after failed stereotactic radiosurgery: a multi-institutional retrospective study. [PDF]

J Neurooncol
Friso F, Ben Dor N, Conti A, Decio Fabbri A, Calvaruso F, Dallari V, De Cecco F, Bochicchio FF, La Corte E, Wojciechowski T, Niemczyk K, Drożdż A, Turek G, Anschuetz L, Soloperto D, Pavesi G, Masotto B, Marchioni D, Sturiale C, Ferroli P, DiMeco F, Presutti L, Molinari G.   +22 more
europepmc   +1 more source

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma. [PDF]

Redox Biol
Skeie BS, Craig-Craven AR, Grüner ER, Biermann M, Riemer F, Bragstad S, Sarowar S, Behbahani M, Sleire L, Schwarzlmüller T, Goplen D, Heggdal JI, Knisely JPS, Schulder M, Eide GE, Filippi CG, Enger PØ.   +16 more
europepmc   +1 more source

Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma. [PDF]

J Neurooncol
Bindal S, Gonzalez B, Dono A, Riascos R, Zhu JJ, Hsu S, Tandon N, Blanco A, Esquenazi Y, Amsbaugh M.   +9 more
europepmc   +1 more source

Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline

Neurosurgery, 2018
S. Chao, A. D. De Salles, M. Hayashi, M. Levivier, Lijun Ma, R. Martínez, I. Paddick, J. Régis, S. Ryu, B. Slotman, A. Sahgal   +10 more
semanticscholar   +1 more source